Clinical Trial Update: A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients [Phase 1]

View source ↗

Summary

This document reports a completed Phase 1 multiple-ascending dose trial in patients with Type 2 diabetes mellitus, conducted by Eli Lilly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED